Menu

Investors

SEC Filing Details

SEC Filing Details

Document Details

Filing Date
Feb 17, 2023
Document Date
Apr 11, 2023
Form Description
A preliminary proxy statement providing notification matters to be brought to a vote
Filing Group
Proxy Filings
Company
Akebia Therapeutics
Issuer
Akebia Therapeutics, Inc.
Print Page
Email Page
Contact IR
Email Alerts
Tear Sheet

Akebia Therapeutics, Inc.
245 First Street, Suite 1400
Cambridge, MA 02142

Driving Directions

+1 617.871.2098  phone
+1 617.871.2099  fax

Contact Us